Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Hauptmann

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
European Urology|October 4, 2002
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissueRalf Lichtinghagen, Petra B Musholt, Michael Lein, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 11, 2010
Losartan reduces mortality in a genetic model of heart failureSophie Günther, Hideo A Baba, Steffen Hauptmann, et al.
Cancer|June 5, 2003
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinomaCarsten Denkert, Klaus-Jürgen Winzer, Berit-Maria Müller, et al.
Endocrine|July 31, 2016
Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificityTomasz Stokowy, Bartosz Wojtas, Barbara Jarzab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapyBeate Rau, Isrid Sturm, Hermann Lage, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 25, 2006
Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinomaMartin Köbel, Elise Gradhand, Katharina Zeng, et al.
The New England Journal of Medicine|December 22, 2022
Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic PurpuraLars M Asmis, Andreas Serra, Alexander Krafft, et al.
The Journal of Urology|December 11, 2003
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancerCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
International Journal of Cancer|May 7, 2002
An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigationCarsten Stephan, Klaus Jung, Henning Cammann, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
European Urology|October 4, 2002
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissueRalf Lichtinghagen, Petra B Musholt, Michael Lein, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 11, 2010
Losartan reduces mortality in a genetic model of heart failureSophie Günther, Hideo A Baba, Steffen Hauptmann, et al.
Cancer|June 5, 2003
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinomaCarsten Denkert, Klaus-Jürgen Winzer, Berit-Maria Müller, et al.
Endocrine|July 31, 2016
Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificityTomasz Stokowy, Bartosz Wojtas, Barbara Jarzab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapyBeate Rau, Isrid Sturm, Hermann Lage, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 25, 2006
Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinomaMartin Köbel, Elise Gradhand, Katharina Zeng, et al.
The New England Journal of Medicine|December 22, 2022
Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic PurpuraLars M Asmis, Andreas Serra, Alexander Krafft, et al.
The Journal of Urology|December 11, 2003
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancerCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
International Journal of Cancer|May 7, 2002
An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigationCarsten Stephan, Klaus Jung, Henning Cammann, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Pageof 9